Anti-mitochondrial M2 Antibodies Enhance the Risk of Supraventricular Arrhythmias in Patients with Elevated Hepatobiliary Enzyme Levels

MLA

Seimi Satomi-Kobayashi, et al. “Anti-Mitochondrial M2 Antibodies Enhance the Risk of Supraventricular Arrhythmias in Patients with Elevated Hepatobiliary Enzyme Levels.” Internal Medicine, vol. 56, no. 14, Jan. 2017, pp. 1771–79. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....18ce8e1486db746c4b6fc9775057ffa4&authtype=sso&custid=ns315887.

APA

Seimi Satomi-Kobayashi, Hiroki Konishi, Yoshihiko Yano, Atsushi Suzuki, Koji Fukuzawa, Kunihiko Kiuchi, Shumpei Mori, Akihiro Yoshida, & Ken-ichi Hirata. (2017). Anti-mitochondrial M2 Antibodies Enhance the Risk of Supraventricular Arrhythmias in Patients with Elevated Hepatobiliary Enzyme Levels. Internal Medicine, 56(14), 1771–1779.

Chicago

Seimi Satomi-Kobayashi, Hiroki Konishi, Yoshihiko Yano, Atsushi Suzuki, Koji Fukuzawa, Kunihiko Kiuchi, Shumpei Mori, Akihiro Yoshida, and Ken-ichi Hirata. 2017. “Anti-Mitochondrial M2 Antibodies Enhance the Risk of Supraventricular Arrhythmias in Patients with Elevated Hepatobiliary Enzyme Levels.” Internal Medicine 56 (14): 1771–79. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....18ce8e1486db746c4b6fc9775057ffa4&authtype=sso&custid=ns315887.